Efficacy and Safety of Upadacitinib in Rheumatoid Arthritis: Real-Life Experience from a Prospective Longitudinal Multicentric Study
Article in Journal of Clinical Medicine (January 2024)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
Cost-effectiveness analysis of upadacitinib as a treatment option for patients with rheumatoid arthritis in the Kingdom of Saudi Arabia
Article in Journal of Medical Economics (January 2024)
UPADACITINIB IN ACTION: EFFICACY AND SAFETY IN THE TREATMENT OF RHEUMATOID ARTHRITIS, PSORIATIC ARTHRITIS, AND AXIAL SPONDYLOARTHRITIS
Article in Rheumatology Quarterly (September 2023)